Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
CMTAreportSummer2022web
…the community. PIT CREW CHIEF AMY builds the STAR agenda for the event, extending invitations to researchers and biopharmaceutical partners to showcase the CMTA’s overarching research strategy, key research projects…
Seattle Focus Group with Acceleron Pharma
We are pleased to announce another opportunity to get involved with the CMTA’s Patients as Partners in Research initiative! The goal of Patients as Partners in Research is to advance…
CMTA’s $450K Investment Targets New Approach to Treatment for Patients with CMT1A and CMT1B
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth (CMT) disease research aimed at bringing treatments to patients, announced today an investment of $450K into a new scientific approach…
A Comprehensive Guide to Clinical Trials
As the CMTA’s $23.5 million investment in research begins to return dividends, more and more potential treatments are advancing to the clinical trial stage. Here’s a quick guide to clinical…
CMT Awareness Month 2023
…color print. Check out the Sky of Fame. Register for the 2023 Patient & Research Summit The 2023 CMTA Patient & Research Summit on Saturday, November 4th will offer life-improving…
For Researchers & Industry
CMTA and ToolGen Announce CMT1A Collaboration
…CMTA has been able to establish research partnerships with almost 40 pharmaceutical and biotech companies, and leading research labs around the world.” The testing alliance with ToolGen involves access to…
Progress Update: Timmerman’s CMT1A Organoid Project Shows Early Success
…stay current on this and all other CMT research and CMTA news. Create Your Patients as Partners in Research Profile Sign up for CMTA eNews Published On: October 29, 2024…
CMTA’s $240K Investment Targets Gene Replacement Therapy in CMT4 Subtypes
…the Strategy to Accelerate Research (STAR) initiative, CMTA has been at the forefront of accelerating gene replacement therapies for CMT, underscoring our leadership in this critical area of research,” said…
Diana Bharucha-Goebel, MD Joins the CMTA-STAR Advisory Board
In a suite of exciting appointments, the Charcot-Marie-Tooth Association (CMTA) Strategy to Accelerate Research (STAR) Advisory Board is delighted to announce the appointment of Dr. Diana Bharucha-Goebel to their Clinical…